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The potential of magnetic nanoparticles for 
biomedical applications has been recognized, due 
to their unique size and physicochemical 
properties. Nanoparticles with superparamagnetic 
behavior are preferred for these purposes, as they 
exhibit a strong magnetization only when an 
external magnetic field is applied [1]. Liposomes 
entrapping magnetic nanoparticles (magnetic 
liposomes) can be guided and localized in the 
therapeutic site by external magnetic field 
gradients and used in cancer therapy by 
hyperthermia, while acting as carriers for 
chemotherapy agents [2].  
In this work, iron oxide nanoparticles (NPs), with 
diameters around 12 nm, were synthesized by 
coprecipitation method (Figure 1). The magnetic 
properties indicate a superparamagnetic behavior 
with a coercive field of 9.7 Oe and a blocking 
temperature of 118 K. Both aqueous and solid 
magnetic liposomes containing magnetite NPs 
were obtained, with sizes below 140 nm (Figure 2). 
Interaction between both types of magnetic 
liposomes and models of biological membranes 
was proven. A new antitumor compound, a 
diarylurea derivative of thienopyridine (Figure 3), 
active against breast cancer, was incorporated in 
both aqueous and solid magnetoliposomes, being 
located mainly in the lipid membrane. A promising 
application of these magnetic liposomes in 
oncology is anticipated, allowing a combined 
therapeutic approach, using both chemotherapy 
and magnetic hyperthermia. 
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Figure 1: SEM image of magnetite nanoparticles. Inset: Particles size 
histogram and fitting to a Gaussian distribution. 
 
 
 
Figure 2: SEM image of solid magnetic liposomes. 
 
 
 
Figure 3: Structure of the antitumor diarylurea derivative of 
thienopyridine. 
